Seagen signs $4.5 Billion deal with Merck Archives

Is Seagen (SGEN) making Money?

October 15, 2020October 15, 2020 daniel Can Seagen Make Money from Breast Cancer?, How Much Cash is Seagen generating?, Is Seagen (SGEN) making Money?, Is there a Healthcare Stock Bubble?, ladiratuzumab vedotin, Seagen (NASDAQ: SGEN), Seagen (SGEN), Seagen Inc. (NASDAQ: SGEN), Seagen signs $4.5 Billion deal with Merck, Seattle Genetics (SGEN), The Health Stock Bubble, Why You Need to Avoid Seagen

However, Seagen (NASDAQ: SGEN) is not making money from its cancer drugs. For instance, Seagen reported a quarterly operating loss of -$93.97 million on 30 June 2020.